1. The rate of radioactive vitamin B12 excretion into plasma and bile from the isolated perfused rat liver and into bile in vivo has been measured after the intramuscular injection of radioactive cyanocobalamin at various time-intervals before study.
Introduction
After administration of trace doses of radioactive vitamin B l z to man and other animals, equilibration of the isotopic vitamin Blz with total vitamin Blz in the body is achieved within 30-70 days in man (Reizenstein, 1959a Hall, 1964 Reizenstein, Ek & Matthews, 1966) , 14 days in the dog (Cooperman, Luhby, Teller & Marley, 1960) and 31 days in the rat (Grasbeck, Ignatius, Jarnefelt, Linddn & Mali, 1961) .
A period of rapid decline in whole-body radioactivity is first observed before a terminal exponential decay curve emerges (Grasbeck, Nyberg & Reizenstein, 1958; Willigan, Cronkite, Meyer & Noto, 1958; Hall, 1964) . Despite the rapid decrease of total body radioactivity observed in the early period, the liver continues to take up radioactive vitamin B12, and a period of several days to more than a week elapses before maximum values of hepatic radioactivity are obtained (Glass, Boyd, Gellin & Stephanson, 1954; Glass, Boyd & Gellin, 1955; Booth & Mollin, 1956; Meyer, Arkun & Jiminez-Casado, 1956 ). The dynamic characteristics of hepatic vitamin B, release are relevant to studies of vitamin B I Z metabolism which depend upon measurement of radioactivity in liver, blood and urine over short intervals of time after the administration of radioactive cyanocobalamin. In the present study, we have measured net uptake and release of hepatic vitamin B1 at short intervals after isotope administration in vivo, and compared the results with studies carried out after a longer time-interval (Cooksley, England, Louis, Down & Tavill, 1974) .
Materials and methods

Labelling of liver in vivo
7Co-labelled cyanocobalamin (3 pCi equivalent to approximately 15 pmol, The Radiochemical Centre or Philips-Duphar, specific radioactivity > 203 pCi/nmol) was administered intramuscularly to 34-month-old male Sprague-Dawley rats at a specified interval of time before perfusion. In some animals, 58Co-labelled cyanocobalamin (1 pCi equivalent to approximately 240 pmol, The Radiochemical Centre, specific radioactivity 4.5 pCi/nmol) was also administered 18 h before liver isolation and perfusion. The rats were fed throughout on a standard laboratory diet (Spratts Laboratory Diet no. 1) containing 11.1 pmol/g of vitamin B12. The amounts of vitamin Blz in the injected dose taken up by the liver, approximately 0.7 pmol of 7Co-labelled vitamin B12 and approximately 7 pmol of 58Co-labelled vitamin Blz, are equivalent to about 0.1 % and 1 % respectively of the normal hepatic vitamin B12 content of 740 pmol (Peterson, Dick & Johansson, 1953; Booth & Spray, 1960) .
Isolated perfused liver
Liver perfusion, measurement of released radioactive vitamin B1 and inhibition of protein synthesis. Details of procedures have previously been described (Cooksley et al., 1974) . To inhibit protein synthesis cycloheximide (Sigma Chemical Co.) freshly prepared in distilled water was added in a single injection of 0.5 ml to the perfusate in the reservoir at the commencement of perfusion to achieve a perfusate plasma concentration of 10 pmol/l.
Uptake of radioactive cyanocobalamin. After incubation of [ 57Co]cyanocobalamin (0.1 pCi, 0.5 pmol) with 1 ml of rat plasma (approximate vitamin B12 binding capacity 3 pmol) at 37°C for 15 min, the labelled plasma was added to the circulating perfusate of the isolated perfused liver.
Fractionation of liver homogenates
At 24 days or 18 h after the parenteral administration of [57Co]cyanocobalamin (6 pCi), the liver was removed, immediately cooled and homogenized in 2 vol. of ice-cold NaCl (150 mmol/l) with a Teflonglass homogenizer. After centrifugation of the homogenate at 105 000 gav. for 80 min the supernatant was removed and injected into several intramuscular sites of other rats. In one experiment the washed pellet was resuspended in 10 ml of NaCl(l50 mmol/l) and injected into a rat at several intramuscular sites.
Maximum precautions were taken to exclude light throughout, including manipulations being performed in a dark room, and the use of aluminium foil to enclose the samples. From sucrose homogenates (lo%, w/v, in 250 mmol/l sucrose) similarly prepared, the yield of radioactivity in the supernatant represented 28% of the hepatic radioactivity after a 'recent' injection and 22% after a 'remote' injection of s7Co-labelled vitamin BI2 compared with 23% and 16% respectively in the 150 mmol/l NaCl preparations. 
Experiments and results
Rate of release of radioactive vitamin B12 into plasma and bile after recent and remote administration of radioactive cyanocobalamin Linear release of 7Co-labelled vitamin B into perfusate plasma and bile was observed during a 4 h perfusion when the [ 7Co]cyanocobalamin had been administered to the rat more than a week before liver perfusion. The rate of release into perfusate plasma was approximately 1 %/h of hepatic radioactivity (Fig. 1) . In contrast, when the radioactive vitamin B12 has been administered to the rat less than a week before perfusion, a biphasic release into perfusate plasma was observed, and the amount of 57Co-labelled vitamin B1 released was considerably greater. For example, the total 57Co-labelled vitamin B l z released into plasma from a liver labelled 4 days before isolation was 15% in 4 h (Fig. 1) . As the interval diminished between parenteral administration of 57Co-labelled vitamin B1 in vivo and isolated liver perfusion a higher rate of release of 5 7 c~-labelled vitamin B I Z into plasma and bile was observed (Fig. 2) .
The administration of [' 7Co]cyanocobalamin and [58Co]cyanocobalamin to the same rat at different time-intervals before perfusion enabled direct comparison of rates of release in the same animal. The release into plasma (25%) and bile (5%) in 4 h of 58Co-labelled vitamin B, , administered 18 h before perfusion was greater than that of 7Co-labelled vitamin B,, administered to the same animal more than a week before perfusion (Fig. 3) . The rate of release of 58Co-labelled vitamin B1 , into both bile and plasma was non-linear, the major release being during the first hour of perfusion with a progressive fall in rate thereafter. When [57Co]cyanocobalamin (0.6 pCi, 3 pmol), after incubation with 1 ml of rat plasma for 15 min at 3 7 T , was injected directly into the portal vein in vivo 10 min before isolated organ perfusion the release of 57Co-labelled vitamin Blz was even greater (90% in 4 h, Table 1 ). The stability of hepatic radioactive vitamin B, , at three different time-intervals between administration and isolated liver perfusion is shown in Fig. 4 .
Uptake of 57Co-labelled vitamin B I Z by the isolated perfused liver
After the administration of radioactive cyanocobalamin to the perfusate of the isolated liver the net hepatic uptake in three separate experiments in 4 h was only 1 4 4 % of the administered dose. The rate of release of radioactive vitamin B12 into bile, after a delay period of half an hour, was linear throughout the period of study at 11, 5.6 and 4.3 %/h of the final hepatic radioactivity.
Rate of release of radioactive vitamin B12 into bile in vivo after recent and remote administration of radioactive cyanocobalamin
A rat to which 3 ,uCi of [57Co]cyanocobalamin had been administered 10 days previously was anaesthetized with ether and the bile duct cannulated with Portex P-10 tubing. The animal was allowed to recover and bile was collected over hourly intervals throughout 4 h. After 2 h the animal was injected with 0.25 pCi of [58Co]cyanocobalamin. At the end of the collection period the animal was killed, the liver removed and homogenized and the total hepatic radioactivity of each isotope determined by measuring in their respective channels with calculations allowing for 'cross-over'. The radioactivity of each isotope in bile was similarly counted. The biliary excretion of 57Co-labelled vitamin B I Z was linear at a rate of 0.19%/h of the final hepatic radioactivity, in contrast to the biliary excretion of 58Co-labelled vitamin B,, which, after a half-hour delay, increased progressively and after 2 h constituted 3.5%/h of the final hepatic radioactivity.
Effects of cycloheximide on vitamin B 1 , release Cycloheximide in the dose administered, to achieve a perfusate plasma concentration of 10-18 ,umol/l, has been shown to be capable of inhibiting the synthesis of albumin and transcobalamin I1 by the isolated perfused rat liver (Cooksley et al., 1974) (Cooksley et al., 1974) , indicating that the release of both forms of vitamin Biz from the liver is independent of protein synthesis.
Eflects of substrate vitamin B l z dosage on the pattern of hepatic release of radioactive vitamin B12
Different amounts of radioactively labelled cyanocobalamin were administered to rats 18 h before was no more labile, suggesting that the rate of conversion from a recent to a remote pool is independent of the quantity of the substrate.
Efect of sodium phenobarbitone administration
[ 7Co]Cyanocobalamin was administered 18 h before isolated liver perfusion to rats which had received parenteral sodium phenobarbitone (0.4 mmolikg daily for 5 days) in order to determine if induction of microsomal enzymes is accompanied by changes in the dynamics of 'Co-labelled vitamin isolated organ perfusion to determine if the rate of B12 release. No differences in the rate or pattern of conversion from 'recent' to 'remote' patterns of release from normal were observed (Table 1) .
release was dependent on substrate dosage. Three different doses of labelled cyanocobalamin were administered (0.44 mol, l.l nmol and 44 mol)
Rate of release of 57Co-labelled vitamin Blz after
nmol is retained by the body, the rest being excreted [ 7Co]Cyanocobalamin (6 ,uCi) was administered in the urine, and the retained dose represents about to rats at either 24 days or 18 h before they were twenty times the normal hepatic vitamin B l z store.
killed. The animals were killed, the liver was The rate and pattern of release of radioactive vitamin removed and homogenized, and preparations B12 by the perfused liver was similar to that observed obtained from the liver homogenates were injected after trace doses. Therefore, despite this thousandfold intramuscularly into other rats 18 h before isolated increase of dosage, the radioactive vitamin B12 pool liver perfusion (see the Materials and Methods ( The release of 57Co-labelled vitamin B12 from the isolated liver of rats injected with the 105 000 gav. supernatant from the 'recently' labelled liver homogenate (17% in 4 h) was similar to that from livers recently labelled directly with [ 7Co]cyanocobalamin, indicating that the dynamic characteristics of the labile pool are not altered by passage through another animal. The release of 7Co-labelled vitamin B1 during isolated liver perfusion from two animals injected with the 105 000 gav. supernatant of liver homogenate from rats labelled 24 days previously was 6.5% and 7 5 % in 4 h, suggesting that the 57Co-labelled vitamin B1 behaved as a 'remote' label even though it had been reinjected only 18 h before an isolated liver perfusion.
Separation of the homogenate of a recently labelled liver into subcellular fractions by ultracentrifugation at 105 000 gav. enabled injection of supernatant and pellet into different animals to test the possibility that the 'recent' and 'remote' pools may be related to their subcellular localization. Patterns of release during liver perfusion were similar in animals injected with supernatant and pellet, making this hypothesis unlikely ( Table 1) .
Changes in radioactivity of tissues at various intervals of time after administration of radioactive cyanocobalamin
Two male rats injected with 3 pCi of [57Co]cyanocobalamin 6 weeks previously were injected with 1 pCi of [ 8Co]cyanocobalamin 1 day and 4 days before killing respectively. Organs or aliquots of tissue were rinsed in ice-cold NaCl (0.15 mol/l) blotted, weighed, and the radioactivity of each isotope was measured by counting in their respective channels with calculations allowing for cross-over, and expressed as a percentage of the injected dose present per g of tissues ( Table 2 ). In the two rats the radioactivities of the various organs were similar after 'remote' labelling. The liver was the organ with the maximum total radioactivity content although other organs had higher radioactivity per gram of tissue. For example, the total radioactivity in the kidneys at 42 days was 37% and 34% of the liver content. The radioactivity in all organs studied was greater after 'recent labelling' compared with 'remote labelling', with the exception of heart and liver. Only in the liver did the radioactive content increase substantially with time, ultimately reaching a value nearly double that at 18 h.
Discussion
The observation that the release of vitamin BIZ from the isolated perfused rat liver differs markedly in both rate and pattern in animals recently labelled compared with those labelled at a more remote period before isolated organ perfusion, provides evidence of heterogeneity of the hepatic vitamin B1 derived from cyanocobalamin.
After the parenteral administration of radioactive cyanocobalamin to rats less than a week before perfusion, the rate of release, although quite variable, was very much greater than that after a 'remote' label. In the most extreme example, labelling 10 min before isolation resulted in the release of 90% of hepatic radioactivity in 4 h. Further evidence of the rapid release of recently administered vitamin B1 was a net hepatic uptake of less than 5% of the dose when the radioactive cyanocobalamin was added to the perfusate, and the release into bile relative to the final hepatic radioactivity was very much greater than that after labelling at a 'remote' period in vivo. The use of two isotopic forms of cyanocobalamin administered at different times to the same animal confirmed the coexistence of different pools within the liver. Heterogeneity of hepatic vitamin BI2 could also be demonstrated in vivo on the basis of the biliary radioactivity release. The biphasic nature of radioactive vitamin B I Z excretion in bile after a 'recent' label suggests that the early rapid release may be from the 'labile' pool and the later slower release from the more 'stable' pool. It is likely, however, that release is more complex than can be explained by a two-compartment model since the characteristics of the hepatic decay curves (Fig. 4) require more than two exponential components. By 10 days the vitamin B12 had probably been converted into the stable form, and thereafter constant release of vitamin B I 2 from the perfused liver occurs (Cooksley et al., 1974) .
The evidence for rapid release of radioactivity from the liver during the early period after the administration of radioactive cyanocobalamin and the time-related acquisition of stability of hepatic radioactive vitamin BI2 offers an explanation for previous data. Several studies Willigan etal., 1958; Hall, 1964) have shown that the excretion of labelled vitamin B12 into bile, and the loss from the body in both faeces and urine, is relatively high during the first few days after administration. Radioactivity in the liver, in contrast to that in many other tissues, increases during this period to reach a maximum after several days to more than a week in different species (Glass et al., 1954 (Glass et al., , 1955 Booth & Mollin, 1956; Meyer et al., 1956; Grasbeck et al., 1961) . The liver, and to a lesser degree the heart, were the only organs whose radioactive content was higher in the late period after isotope administration. The increase in radioactivity in the liver parallels the decrease in the other tissues and indicates that the liver, in contrast to other tissues, has a greater role in the stabilization and storage of vitamin B1 2 . Explanations for this net expansion of the intrahepatic pool of vitamin B12 are either an increase in hepatic uptake or a decrease in hepatic release. The marked change we have demonstrated in the rate of hepatic release which occurs during the first week suggests that this net increase in hepatic radioactivity is partly due to a decrease in the rate of hepatic release, although a progressive increase in uptake of vitamin B12 released by other issues may also contribute.
Several factors which might affect the stabilization of hepatic vitamin B12 were examined. Although cycloheximide inhibited the release of transcobalamin I1 by the isolated perfused liver (Cooksley et al., 1974) it failed to inhibit the release of either the stable pool (Cooksley et al., 1974) or the labile, recently labelled pool of vitamin B12. This suggests that neither form of vitamin B i z is released from the liver in complex with newly synthesized protein.
Neither marked increases in the amount of vitamin B1 z administered nor phenobarbitone administration in vivo altered the behaviour of the recently injected vitamin Blz (Table 1 ). The period taken for conversion from a labile into a stable form of vitamin BI2 is therefore independent of the amount of substrate, and is unaffected by a commonly used hepatic microsomal enzyme-inducing agent.
Experiments involving the recent injection into rats of preparations of rat liver remotely labelled in vivo with radioactive cyanocobalamin showed that the characteristics of stability acquired by passage through another animal were retained, and demonstrated that the form of the vitamin B12 rather than the presence of multiple anatomical compartments with slow equilibration is responsible for the hepatic heterogeneity. Although Reizenstein (1959a) originally suggested that anatomical compartmentation may underlie the multi-exponential whole-body decay curves, it is possible that the multiple chemical forms of vitamin B1 2 derived from the conversion of cyanocobalamin may be a more reasonable explanation for the complex excretion curve (Rosenblum, Reizenstein, Cronkite & Meriwether, 1963 ; Reizenstein et al., 1966) .
One important consequence of multiple labelled intrahepatic pools of vitamin B12 lies in the observation of the extremely rapid rate of release from the more labile pools. After the administration of radioactive cyanocobalamin, radioactivity in plasma and bile will not reflect the behaviour of physiological vitamin B12 until a relatively long time has elapsed (Okuda, Grasbeck & Chow, 1958; Reizenstein, 1959b; England, Clarke, Down & Chanarin, 1973) . In the presence of rapid fluxes from the plasma (Hall, 1960) and into the plasma, experiments in vivo which involve the sequential measurement of plasma radioactivity after the acute administration of labelled cyanocobalamin are liable to difficulties of interpretation, since plasma radioactivity reflects the net result of release and uptake and will be profoundly influenced by non-steady-state conditions of release from heterogeneous pools.
The ability of the liver to stabilize vitamin B1 compared with other organs may partly reflect its functional role as the major storage site of vitamin B12 in the body. Although the concentrations of vitamin B12 in the body may be higher in some other organs, the liver because of its size remains the predominant site of storage. Although this acquisition appears to be a function of the liver relative to the other organs, the exact site of metabolic conversion in the body is uncertain.
